Effect of Enoxaparin on serum level of activated anti-factor XA in myocardial infarction patients with acute coronary syndrome
Phase 2
Recruiting
- Conditions
- Myocardial infarction with acute coronary syndrome.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
- Registration Number
- IRCT20120215009014N198
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Age of 18 to 90 years
myocardial infarction with acute coronary syndrome
Exclusion Criteria
Low blood platelet
Heparin induced thrombocytopenia
Uncontrolled hypertension
Bacterial endocarditis
Hemorrhagic stroke
Gastric or duodenal ulcer
Severe renal insufficiency
Diabetic retinopathy
Coagulation disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing serum level of activated anti-factor XA. Timepoint: Before intervention and 12 hours after intervention. Method of measurement: Through laboratory test.
- Secondary Outcome Measures
Name Time Method